A decade of HPLC-MS/MS in the routine clinical laboratory--goals for further developments.
about
A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose.Liquid chromatography-mass spectrometry: a tool for proteome analysis and biomarker discovery and validation.Unbiased approaches to biomarker discovery in neurodegenerative diseasesDetermination of rivaroxaban in patient's plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS).Pathology interface for the molecular analysis of tissue by mass spectrometry.National Estimates of Serum Total 25-Hydroxyvitamin D and Metabolite Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry in the US Population during 2007-2010.Advances in biochemical screening for phaeochromocytoma using biogenic aminesHow close is the bench to the bedside? Metabolic profiling in cancer research.Advances in mass spectrometry applied to pharmaceutical metabolomics.Fast liquid chromatography combined with mass spectrometry for the analysis of metabolites and proteins in human body fluids.Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods.Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies.Challenges and benefits of endogenous steroid analysis by LC-MS/MS.High-field asymmetric waveform ion mobility spectrometry with solvent vapor addition: a potential greener bioanalytical technique.Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.Mass spectrometry and NMR spectroscopy: modern high-end detectors for high resolution separation techniques--state of the art in natural product HPLC-MS, HPLC-NMR, and CE-MS hyphenations.Ethics of drug research in the pediatric intensive care unit.Recent applications of CE- and HPLC-MS in the analysis of human fluids.Application of high-resolution MS for development of peptide and large-molecule drug candidates.Ultra high performance liquid chromatography-tandem mass spectrometry vs. commercial immunoassay for determination of vancomycin plasma concentration in children. Possible implications for everyday clinical practice.Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry.An on-line solid phase extraction procedure for the routine quantification of urinary methylmalonic acid by liquid chromatography-tandem mass spectrometry.Sample preparation for liquid chromatographic analysis of phytochemicals in biological fluids.A routine method for the quantification of the novel antimycotic drug posaconazole in plasma using liquid chromatography-tandem mass spectrometry.A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples.Quantitative plasma analysis using automated online solid-phase extraction with column switching LC-MS/MS for characterising cytochrome P450 2D6 and 2C19 metabolism.Sample preparation for large-scale bioanalytical studies based on liquid chromatographic techniques.Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patients.The safety and efficacy of short-term budesonide delivered via mucosal atomization device for chronic rhinosinusitis without nasal polyposis.Proper Controls to Electrochemically Evaluate Carotenoids using β-Cyclodextrin Modified Surfaces.A DNA-Based Assay for Digoxin Detection.
P2860
Q33447122-5A0B4D52-DF3F-4F82-8542-B0A2F1BA71C6Q33457379-7AA2DEBE-92A7-4D85-BCD3-55A836D34668Q34625918-8C0611D5-F32C-4B0C-BA11-5FD08687043EQ36272889-3934D4D3-12C1-48F8-A145-FA7AC0B00882Q36816099-EF10F0D4-2180-4ACB-ACF1-7BBD633576DEQ36827937-CCD00837-7E2F-44A1-9D21-DAE596149000Q37098116-60B4D5A9-7676-4175-B2BE-E6BAD608270DQ37118287-7AA9F6C1-45DD-4A23-B3C6-6D4160AC77FAQ37812335-48B2EB01-D7CE-4D9D-8147-36A4CBB3F825Q37831178-378CA8CB-E552-4DE3-84D8-3DC13D8DD64AQ37866806-00E3DBFE-CAA4-4A2B-ADF2-407AF5EC276BQ37914111-3DC55CCE-3026-480A-B0F4-8043F47109E7Q37961970-17D8B6E5-E548-4F21-90AD-828472F1ACC0Q38020526-81F68719-4FC7-40DD-B181-A433124E9471Q38058053-0B361732-7ED8-46B7-906E-8C92901C09A0Q38112324-3C37E8B0-5E63-4F09-846B-17E25F582C37Q38263726-4AC4A46C-A8E7-46BF-B4DF-68173FBFE386Q38596722-4C08AECE-2DE0-4BB3-8EF4-63EB2B7C4C38Q40077940-97C59F1F-A7CB-4468-8E1A-E7408ACCDF81Q40654353-D914677C-484A-4F0C-927B-7D301DD28C91Q41181275-26752A43-73DC-4CBD-A4F6-2D459360EC5BQ42939585-531DEFA5-35AE-403A-B4E3-101B87214C3DQ44700982-2E641826-3233-4C9E-84D1-790E2B5AB3B2Q45172325-5DCAB42C-E428-4599-8B01-86D2F430FC33Q46072595-A224A103-364F-4619-B60C-A51D350A4F00Q46897823-C0263521-A27F-4340-BA81-A3713E63F0C8Q47396882-42FBBA43-FD82-4FC7-994C-CFAC448B1D8EQ47745108-FAFBE3F6-9A0F-4356-8613-5C56F96E0D1DQ48092547-E142CDE8-A65A-4102-AE17-F054BD590C66Q52606061-030A2019-9889-4FBB-9987-B681095A999DQ55209427-80E5E5C9-B670-41DD-90B8-6FE345A568AB
P2860
A decade of HPLC-MS/MS in the routine clinical laboratory--goals for further developments.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A decade of HPLC-MS/MS in the ...... oals for further developments.
@en
A decade of HPLC-MS/MS in the ...... oals for further developments.
@nl
type
label
A decade of HPLC-MS/MS in the ...... oals for further developments.
@en
A decade of HPLC-MS/MS in the ...... oals for further developments.
@nl
prefLabel
A decade of HPLC-MS/MS in the ...... oals for further developments.
@en
A decade of HPLC-MS/MS in the ...... oals for further developments.
@nl
P1476
A decade of HPLC-MS/MS in the ...... oals for further developments.
@en
P2093
Christoph Seger
Michael Vogeser
P304
P356
10.1016/J.CLINBIOCHEM.2008.02.017
P577
2008-03-14T00:00:00Z